Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Nasal Salmon Calcitonin in the Treatment of Symptoms and Signs of Fibromyalgia

NCT00754884 is registered in ClinicalTrials.gov with Unidad de Investigacion en Enfermedades Cronico-Degenerativas as lead sponsor.

NCT NCT00754884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00754884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Nasal Salmon Calcitonin in the Treatment of Symptoms and Signs of Fibromyalgia
Lead sponsor
Unidad de Investigacion en Enfermedades Cronico-Degenerativas
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2008
Completion date
February 28, 2009
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia